172 related articles for article (PubMed ID: 36281082)
21. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
24. Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma.
Zhu S; Lin F; Chen Z; Jiang X; Zhang J; Yang Q; Chen Y; Wang J
Front Genet; 2020; 11():563882. PubMed ID: 33101383
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
Xin W; Zhao C; Jiang L; Pei D; Zhao L; Zhang C
Pathol Oncol Res; 2021; 27():585192. PubMed ID: 34257533
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
29. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
30. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
33. Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer.
Zheng J; Cao B; Zhang X; Niu Z; Tong J
Biomed Res Int; 2020; 2020():3641231. PubMed ID: 33274204
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
PeerJ; 2020; 8():e9201. PubMed ID: 32518728
[TBL] [Abstract][Full Text] [Related]
35. SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
Jiang P; Cao Y; Gao F; Sun W; Liu J; Ma Z; Xie M; Fu S
BMC Cancer; 2021 Jun; 21(1):694. PubMed ID: 34116656
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of Gene Expression Profiles Identifies a
Chen Z; Chen M; Xue Z; Zhu X
Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
[No Abstract] [Full Text] [Related]
37. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
38. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
40. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
Li N; Yu K; Lin Z; Zeng D
Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]